Today's story
EU Panel Recommends Lilly’s Foundayo Weight-Loss Pill
EMA's CHMP on Oct. 16, 2026, backed Eli Lilly's once-daily Foundayo pill for weight loss and type 2 diabetes; a European Commission decision usually follows in about two months.
Health · 11 sources · 1dRead itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use (CHMP), formerly known as the Committee for Proprietary Medicinal Products (CPMP), is the European Medicines Agency's committee responsible for elaborating the agency's opinions on all issues regarding medicinal products for human use.
Everything about Committee for Medicinal Products for Human Use →